California Resident Dies Hours After Getting CCP Virus Vaccine

 

 

 

A person in California who received a CCP virus vaccine on Jan. 21 died several hours later, authorities said.

The cause of death isn’t yet clear.

“The vaccine was not administered by Placer County Public Health. There are multiple local, state, and federal agencies actively investigating this case; any reports surrounding the cause of death are premature pending the outcome of the investigation,” the Placer County Sheriff’s Office said in a statement.

Authorities didn’t disclose identifying characteristics of the individual or say whether the vaccine was produced by Moderna or Pfizer.

One hundred and forty-nine people have died in the United States after getting a CCP (Chinese Communist Party) virus vaccine, according to reports submitted to the passive Vaccine Adverse Event Reporting System. Anyone can submit reports to the federal database and the reports are generally impossible to verify, a Food and Drug Administration spokeswoman told The Epoch Times via email earlier this month.

The new figure is from an update of reports. Last week, it was at 55.

Authorities do not have a centralized location of verified deaths of people who have been vaccinated. “Any reports of death following the administration of vaccines are promptly and rigorously investigated jointly” by the administration and the Centers for Disease Control and Prevention, the spokeswoman added. The agencies didn’t respond to requests for comment about the California death.

California officials last week directed vaccine providers not to administer any doses from a batch of more than 330,000 that was circulated across the state.

The reason was a “higher-than-usual number of possible allergic reactions,” California State Epidemiologist Dr. Erica Pan said in a statement.

The CCP virus vaccine doses were produced by Moderna.

Moderna, the Centers for Disease Control and Prevention, and the Food and Drug Administration are investigating.

The CCP virus causes the disease COVID-19.

Read Full Article

 

Leave a comment

Please note, comments must be approved before they are published